- Title
- Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
- Creators - without role
- Jun Ho Yi - Chung-Ang UniversitySeok Jin Kim - Samsung Medical CenterDok Hyun Yoon - University of UlsanCheolwon Suh - University of UlsanMyung Hee Chang - National Health Insurance Service Ilsan HospitalDeok Hwan Yang - Chonnam National University Hwasun HospitalJae‐Cheol Jo - Ulsan University HospitalShin Young Hyun - Yonsei UniversityHyeon‐Seok Eom - National Cancer Center, Goyang‐si Gyeonggi‐doJeong‐Ok Lee - Seoul National University Bundang HospitalJi Hyun Kwon - Chungbuk National University HospitalSang Hoon Han - Jeju National UniversitySeung‐Shin Lee - Wonkwang UniversityJae‐Yong Kwak - Jeonbuk National UniversitySe Hyung Kim - Bucheon UniversityDae Sik Kim - Korea University Medical CenterJi Hyun Lee - Dong-A UniversitySung Yong Oh - Dong-A UniversityHun Mo Ryoo - Catholic University of DaeguHyo Jung Kim - Hallym UniversityWon Seog Kim - Samsung Medical Center
- Publication Details
- Cancer communications (London, England), Vol.41(3), pp.275-278
- Publisher
- John Wiley and Sons Inc
- Identifiers
- 9945348308331
- Academic Unit
- King Abdullah University of Science & Technology
- Language
- English
- Resource Type
- Journal article
Journal article
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Cancer communications (London, England), Vol.41(3), pp.275-278
03/2021
PMCID: 7968880
PMID: 33626235
Metrics
5 Record Views